AI investment: Nuritas to step up development after €16m Series A funding
Dublin-based biotech Nuritas says the closing of a €16 million of series A funding will allow it to scale up and grasp the ‘huge opportunities’ for the discovery and use of bioactive peptides through artificial intelligence (AI) and genomics.